Kinpeygo is indicated for the treatment of adults with primary immunoglobulin A nephropathy (IgAN) with a urine protein excretion ≥1.0 g/day (or urine protein-to-creatinine ratio ≥0.8 g/g).
Prescribing Information can be found here.
Please leave your details below if you would like more information about Kinpeygo. Should you have any trouble completing this form please email us at HCPsupport@thorntonross.com
Required fields are marked with an asterisk *
Adverse events should be reported. Reporting forms and information can be found at yellowcard.mhra.gov.uk or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Thornton and Ross Limited by emailing thorntonross@medinformation.co.uk or by calling 01484 848164.
UK-KINPE-56(2) | June 2025